A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer
Bang, Y.-J., Kang, Y.-K., Ng, M., Chung, H.C., Wainberg, Z.A., Gendreau, S., Chan, W.Y., Xu, N., Maslyar, D., Meng, R., Chau, I., Ajani, J.A.
Published in European journal of cancer (1990) (01.02.2019)
Published in European journal of cancer (1990) (01.02.2019)
Get full text
Journal Article
Anti-NaPi2b antibody–drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study
Banerjee, S., Oza, A.M., Birrer, M.J., Hamilton, E.P., Hasan, J., Leary, A., Moore, K.N., Mackowiak-Matejczyk, B., Pikiel, J., Ray-Coquard, I., Trask, P., Lin, K., Schuth, E., Vaze, A., Choi, Y., Marsters, J.C., Maslyar, D.J., Lemahieu, V., Wang, Y., Humke, E.W., Liu, J.F.
Published in Annals of oncology (01.04.2018)
Published in Annals of oncology (01.04.2018)
Get full text
Journal Article
Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody–drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer
Liu, J.F., Moore, K.N., Birrer, M.J., Berlin, S., Matulonis, U.A., Infante, J.R., Wolpin, B., Poon, K.A., Firestein, R., Xu, J., Kahn, R., Wang, Y., Wood, K., Darbonne, W.C., Lackner, M.R., Kelley, S.K., Lu, X., Choi, Y.J., Maslyar, D., Humke, E.W., Burris, H.A.
Published in Annals of oncology (01.11.2016)
Published in Annals of oncology (01.11.2016)
Get full text
Journal Article
Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors
Isakoff, S.J., Tabernero, J., Molife, L.R., Soria, J.-C., Cervantes, A., Vogelzang, N.J., Patel, M.R., Hussain, M., Baron, A., Argilés, G., Conkling, P.R., Sampath, D., Maslyar, D., Patel, P., Chan, W., Gendreau, S., Musib, L., Xu, N., Ma, H., Lin, K., Bendell, J.
Published in Annals of oncology (01.05.2020)
Published in Annals of oncology (01.05.2020)
Get full text
Journal Article
Small-Molecule Antagonists of Myc/Max Dimerization Inhibit Myc-Induced Transformation of Chicken Embryo Fibroblasts
Berg, Thorsten, Cohen, Steven B., Desharnais, Joel, Sonderegger, Corinna, Maslyar, Daniel J., Goldberg, Joel, Boger, Dale L., Vogt, Peter K.
Published in Proceedings of the National Academy of Sciences - PNAS (19.03.2002)
Published in Proceedings of the National Academy of Sciences - PNAS (19.03.2002)
Get full text
Journal Article
630. A Phase 2 Randomized Study of GM-CSF Gene-Modified Autologous Tumor Cell Immunotherapy (CG8123) with and without Low- Dose Cyclophosphamide in Advanced Stage Non- Small Cell Lung Cancer (NSCLC)
Nemunaitis, John, Schiller, J., Ross, Helen, Jablons, David, Harper, H., Sterman, D., Kelly, K., Carbone, D., Lin, A., Maslyar, D., Hege, Kristen
Published in Molecular therapy (01.05.2006)
Published in Molecular therapy (01.05.2006)
Get full text
Journal Article
Oncogenic transformation by beta-catenin: deletion analysis and characterization of selected target genes
Aoki, Masahiro, Sobek, Vera, Maslyar, Daniel J, Hecht, Andreas, Vogt, Peter K
Published in Oncogene (10.10.2002)
Published in Oncogene (10.10.2002)
Get full text
Journal Article
PTEN loss as a predictive biomarker for the Akt inhibitor ipatasertib combined with abiraterone acetate in patients with metastatic castration-resistant prostate cancer (mCRPC)
de Bono, J.S., De Giorgi, U., Massard, C., Bracarda, S., Nava Rodrigues, D., Kocak, I., Font, A., Arija, J. Arranz, Shih, K., Radavoi, G.D., Yu, W., Chan, W., Gendreau, S., Zhang, L., Riisnaes, R., Wongchenko, M.J., Maslyar, D., Jinga, V.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Randomized phase III trial of ipatasertib vs. placebo, plus abiraterone and prednisone/prednisolone, in men with asymptomatic or mildly symptomatic previously untreated metastatic castrate-resistant prostate cancer (mCRPC)
de Bono, J., Bracarda, S., Chi, K., Massard, C., Olmos Hidalgo, D., Sandhu, S., Sternberg, C.N., Gendreau, S., Xu, N., Baney, T., Maslyar, D., Sweeney, C.J.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Translational Pkpd of Dnib0600A, an Anti-Napi2B-Vc-Mmae Adc in Ovarian and Nsclc Cancers
Lin, K., Sukumaran, S., Xu, J., Zhang, C., Choi, Y., Yu, S., Polakis, P., Maslyar, D.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
1598PTRANSLATIONAL PKPD OF DNIB0600A, AN ANTI-NAPI2B-VC-MMAE ADC IN OVARIAN AND NSCLC CANCERS
Lin, K., Sukumaran, S., Xu, J., Zhang, C., Choi, Y., Yu, S., Polakis, P., Maslyar, D.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Spatial patterns of gene expression in Brassica napus seedlings: identification of a cortex-specific gene and localization of mRNAs encoding isocitrate lyase and a polypeptide homologous to proteinases
Dietrich, R.A. (Unviersity of California, Davis, CA), Maslyar, D.J, Heupel, R.C, Harada, J.J
Published in The Plant cell (01.01.1989)
Published in The Plant cell (01.01.1989)
Get full text
Journal Article
Dose-escalation phase I study of NKTR-105, a novel pegylated form of docetaxel
Calvo, E., Hoch, U., Maslyar, D. J., Tolcher, A. W.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
1627PPET-IMAGING WITH 89ZR-LABELED ANTI-MESOTHELIN (MSLN) ANTIBODY IN PATIENTS WITH PANCREATIC CANCER (PC) OR OVARIAN CANCER (OC)
Lamberts, L.E., Menke-van der Houven van Oordt, C.W., Bensch, F., Voortman, J., Hoekstra, O.S., Maslyar, D., Williams, S.P., Fine, B.M., Bongaerts, A.H., Gietema, J.A., Schroder, C.P., Weele, E.J. Ter, Hooge, M.N. Lub-De, Verheul, H.M., Sanabria, S., Glaudemans, A.W.J.M., De Vries, E.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Pet-Imaging with 89Zr-Labeled Anti-Mesothelin (Msln) Antibody in Patients with Pancreatic Cancer (Pc) or Ovarian Cancer (Oc)
Lamberts, L.E., Menke-van der Houven van Oordt, C.W., Bensch, F., Voortman, J., Hoekstra, O.S., Maslyar, D., Williams, S.P., Fine, B.M., Bongaerts, A.H., Gietema, J.A., Schroder, C.P., Te Weele, E.J. r, Hooge, M.N. Lub-De, Verheul, H.M., Sanabria, S., Glaudemans, A.W.J.M., De Vries, E.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Phase II study of NKTR-102 in women with platinum-resistant/refractory ovarian cancer
Vergote, I. B., Micha, J. P., Pippitt, C. H., Rao, G. G., Spitz, D. L., Reed, N., Dark, G. G., Garcia, A., Maslyar, D. J., Rustin, G. J.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Abstract P2-09-20: Biomarker analysis of the LOTUS trial of first-line ipatasertib (IPAT) + paclitaxel (PAC) in metastatic triple-negative breast cancer (TNBC)
Wongchenko, MJ, Dent, R, Kim, S-B, Saura, C, Oliveira, M, Baselga, J, Kapp, AV, Chan, WY, Singel, SM, Maslyar, DJ, Gendreau, S
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article